A233250 logo

Median Diagnostics Inc. Stock Price

XKON:A233250 Community·₩14.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A233250 Share Price Performance

₩8,200.00
-4800.00 (-36.92%)
₩8,200.00
-4800.00 (-36.92%)
Price ₩8,200.00

A233250 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very low risk with weak fundamentals.

2 Risks
0 Rewards

Median Diagnostics Inc. Key Details

₩0

Revenue

₩0

Cost of Revenue

₩0

Gross Profit

₩0

Other Expenses

₩0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About A233250

Founded
1999
Employees
n/a
CEO
Oh Jin-sik
WebsiteView website
www.mediandiagnostics.com

Median Diagnostics Inc. manufactures and sells veterinary medicines and diagnostic reagents. The company’s products include PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; ELISA for pigs, ruminants, avians, and horses; standard reagents, including AGID, HI, and FA; and antigen/antibody, including antibodies for veterinary diagnostics, and antibodies and antigens for human diagnostics. It also offers mouse and rat pathogens and antibodies test, as well as honey authenticity test kit and VDPro JEV AG ELISA. The company was formerly known as JENO Biotech Inc. and changed its name to Median Diagnostics Inc. in July 2011. Median Diagnostics Inc. was founded in 1999 and is headquartered in Chuncheon-si, South Korea.

Recent A233250 News & Updates

Recent updates

No updates